Emerging Markets Earnings Roundup: AbbVie (Part 5)
This article was originally published in PharmAsia News
Executive Summary
AbbVie was required to stay largely mum on its second quarter earnings call as it complies with the UK Takeover Code in its deal with Shire. But some numbers on Humira were released for international sales that show the franchise growing well outside of the U.S.